World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
8030
World Ranking
4138
National Ranking
1604

Thomas F. Wierzba publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas F. Wierzba sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 145 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thomas F. Wierzba D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Wierzba sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Thomas F. Wierzba is affiliated with Wake Forest University in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, and Medicine. The primary subfields of study include Endocrinology, Infectious Diseases, Molecular Medicine, Health, Toxicology and Mutagenesis, and Nutrition and Dietetics.

The scientist's work frequently focuses on key topics such as Escherichia coli research studies, viral gastroenteritis research and epidemiology, antibiotic resistance in bacteria, climate change and health impacts, child nutrition and water access, Vibrio bacteria research studies, and COVID-19 and mental health.

Wierzba has contributed to several publications, with a focus on infectious diseases and vaccine research. Their recent papers include:

  • Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021 (2022, Vaccine X)
  • A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions (2023, Microorganisms)
  • The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin (2023, Microorganisms)
  • Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United States (2024, PLoS ONE)

The primary venues for Wierzba's publications are Microorganisms, Vaccine X, and PLoS ONE, with the highest number of publications appearing in Microorganisms.

Frequent coauthors in Wierzba's research include M. Jahangir Hossain, Ann-Mari Svennerholm, Nils Carlin, Umberto D'Alessandro, and Karoun H. Bagamian.

Best Publications

  • Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

    Vittal Mogasale;Brian Maskery;R Leon Ochiai;Jung Seok Lee

  • Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study

    Florian Marks;Vera von Kalckreuth;Peter Aaby;Yaw Adu-Sarkodie

  • Status of vaccine research and development for Shigella.

    Sachin Mani;Thomas Wierzba;Richard I. Walker

  • 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

    Sujit K Bhattacharya;Dipika Sur;Mohammad Ali;Suman Kanungo

  • Status of vaccine research and development for enterotoxigenic Escherichia coli.

    A. Louis Bourgeois;Thomas F. Wierzba;Richard I. Walker

  • Pathogenicity and Convalescent Excretion of Campylobacter in Rural Egyptian Children

    Malla R. Rao;Abdollah B. Naficy;Stephen J. Savarino;Remon Abu-Elyazeed

  • Early initiation of breastfeeding and the risk of infant diarrhea in rural Egypt.

    J Clemens;R A Elyazeed;M Rao;S Savarino

  • Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.

    Firdausi Qadri;Thomas F. Wierzba;Mohammad Ali;Fahima Chowdhury

  • A systematic review of the epidemiology of hepatitis E virus in Africa

    Jong Hoon Kim;Kenrad E. Nelson;Ursula Panzner;Yogita Kasture

  • Infectious Etiologies of Acute Febrile Illness among Patients Seeking Health Care in South-Central Cambodia

    Matthew R. Kasper;Patrick J. Blair;Sok Touch;Buth Sokhal

  • Epidemiology of Rotavirus Diarrhea in Egyptian Children and Implications for Disease Control

    Abdollah B. Naficy;Remon Abu-Elyazeed;Jennifer L. Holmes;Malla R. Rao

  • Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis

    John D Anderson;John D Anderson;John D Anderson;Karoun H Bagamian;Farzana Muhib;Mirna P Amaya;Mirna P Amaya

  • Phenotypic Profiles of Enterotoxigenic Escherichia coli Associated with Early Childhood Diarrhea in Rural Egypt

    Hind I. Shaheen;Sami B. Khalil;Malla R. Rao;T. Remon Abu Elyazeed

  • Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study

    Ahmed M. Khatib;Mohammad Ali;Lorenz von Seidlein;Deok Ryun Kim

  • Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa.

    Brittany L Kmush;Thomas F Wierzba;Lisa J Krain;Kenrad E Nelson

  • Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine : Results of the initial evaluation in children

    Stephen J. Savarino;Eric R. Hall;Samir Bassily;F. Matthew Brown

  • High Disease Burden of Diarrhea Due to Enterotoxigenic Escherichia coli among Rural Egyptian Infants and Young Children

    Malla R. Rao;Remon Abu-Elyazeed;Stephen J. Savarino;Abdollah B. Naficy

  • Short-Course Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adolescents

    Robert W. Frenck;Adel Mansour;Isabelle Nakhla;Yehia Sultan

  • Diarrhea associated with Cryptosporidium parvum among young children of the Nile River Delta in Egypt.

    Ibrahim Adib Abdel-Messih;Thomas F. Wierzba;Remon Abu-Elyazeed;Abdel Fatah Ibrahim

  • Safety and Immunogenicity of an Oral, Killed Enterotoxigenic Escherichia coli-Cholera Toxin B Subunit Vaccine in Egyptian Adults

    Stephen J. Savarino;F. Matthew Brown;Eric Hall;Samir Bassily

  • DIAGNOSIS AND MANAGEMENT OF DYSENTERY BY COMMUNITY HEALTH WORKERS

    Carine Ronsmans;MichaelL. Bennish;MichaelL. Bennish;Thomas Wierzba

  • Astrovirus Diarrhea in Egyptian Children

    Abdollah B. Naficy;Malla R. Rao;Jennifer L. Holmes;Remon Abu-Elyazeed

Frequent Co-Authors

John D. Clemens
John D. Clemens University of California, Los Angeles
Robert W. Frenck
Robert W. Frenck Cincinnati Children's Hospital Medical Center
Stephen Baker
Stephen Baker Agency for Science, Technology and Research
Robert F. Breiman
Robert F. Breiman Emory University
Peter Aaby
Peter Aaby University of Southern Denmark
Ann-Mari Svennerholm
Ann-Mari Svennerholm University of Gothenburg
John A. Crump
John A. Crump University of Otago
Abraham Aseffa
Abraham Aseffa Armauer Hansen Research Institute
Lorenz von Seidlein
Lorenz von Seidlein Mahidol University
Sujit K. Bhattacharya
Sujit K. Bhattacharya Indian Council of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Microbiology, exploring related online degrees can open doors to diverse career opportunities. Fields such as healthcare, medical coding, and specialized nursing offer promising alternatives that complement a microbiology background.

For example, becoming a child life specialist involves understanding human development and health, with competitive earning potential. Similarly, a career as a functional medicine nurse practitioner merges holistic healthcare with science, offering rewarding salary prospects and growth.

Students concerned about background challenges may find valuable options with college degrees for felons, highlighting accessible pathways to rebuild careers through education. Additionally, becoming a certified professional coder (CPC) leverages attention to detail and knowledge of medical terminology, an excellent fit for microbiology graduates interested in health information management.

Exploring these related degrees and careers can enhance your skill set, improve job security, and expand your professional horizons beyond traditional microbiology roles.

Best Scientists Citing Thomas F. Wierzba

Trending Scientists

Recently Published Articles